Since the introduction of docetaxel, research has focused on various approaches to overcome treatment limitations and improve outcome. This review discusses the pharmacological attempts at treatment optimisation, which include reducing interindividual pharmacokinetic and pharmacodynamic variability, optimising schedule, route of administration, reversing drug resistance and the development of structurally related second-generation taxanes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361544 | PMC |
http://dx.doi.org/10.1038/sj.bjc.6602698 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!